(Q46147769)

English

Scientific and logistical challenges in designing the CONTROL trial: recombinant factor VIIa in severe trauma patients with refractory bleeding

scientific article published on 8 September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

Scientific and logistical challenges in designing the CONTROL trial: recombinant factor VIIa in severe trauma patients with refractory bleeding (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

Kenneth D. Boffard

object named as

Kenneth Boffard

3

0 references

6

object named as

John Holcomb

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

Gordon R. Bernard

5

object named as

Gordon Bernard

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

1 reference

ORCID Public Data File 2021

author name string

Richard Dutton

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

Carl Hauser

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

Jeannett Dimsitts

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

Ari Leppäniemi

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

Bartholemew Tortella

8

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

Bertil Bouillon

9

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

CONTROL Steering Committee

10

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

publication date

8 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

Clinical Trials

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

467-479

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

Prophylactic and therapeutic use of recombinant activated factor VII in patients with cirrhosis and coagulation impairment

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Benefits of recombinant activated factor VII in complicated liver transplantation

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia.

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Intracerebral hemorrhage: natural history and rationale of ultra-early hemostatic therapy

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Efficacy and safety of recombinant activated factor vii in major surgical procedures: systematic review and meta-analysis of randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

The role of recombinant factor VIIa in on-pump cardiac surgery: proceedings of the Canadian Consensus Conference

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion.

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials.

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Recombinant activated factor VII for acute intracerebral hemorrhage.

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage.

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: a multicenter, randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation.

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Epidemiology of trauma deaths: a reassessment

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Early coagulopathy predicts mortality in trauma

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Management of bleeding following major trauma: a European guideline

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Updates in the management of severe coagulopathy in trauma patients

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Coagulopathy: its pathophysiology and treatment in the injured patient

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Goals of therapy in common bleeding emergencies

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding--a European perspective

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Factors associated with hospital mortality in traumatic injuries: incentive for trauma care integration

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Factor VIIa for correction of traumatic coagulopathy

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Current status of blood component therapy in surgical critical care

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Scope of the problem: epidemiology of anemia and use of blood transfusions in critical care

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Efficacy of red blood cell transfusion in the critically ill.

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Perioperative anemia

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Cumulative risks of early red blood cell transfusion

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Acute respiratory distress syndrome: a historical perspective

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Role of intravenous insulin therapy in critically ill patients

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Development of trauma systems and effect on outcomes after injury

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Impediments to obtaining informed consent for clinical research in trauma patients

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

The "golden hour" paradigm

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

The role of data and safety monitoring in acute trauma resuscitation research

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Issues in data monitoring and interim analysis of trials

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Massive transfusion in trauma patients: tissue hemoglobin oxygen saturation predicts poor outcome

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Revisiting transfusion practices in critically ill patients

1 reference

https://api.crossref.org/works/10.1177%2F1740774509344102

21 January 2018

Identifiers

10.1177/1740774509344102

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19737846

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46147769&oldid=2094979132"